Vladimir T. Ivashkin
Moscow, MOW 119435, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
Potassium Homeostasis and the Systemic Consequences of Intracellular Potassium Deficiency: From Molecular Mechanisms to Clinical Manifestations.
Journal: Biomolecules
Published: May 30, 2026
Efficacy and safety of H. pylori eradication therapy in real-world clinical practice: results of the «PAMIR» observational program
Journal: Terapevticheskii arkhiv
Published: May 03, 2026
Treatment of Small Intestinal Bacterial Overgrowth (SIBO) in Gastrointestinal, Hepatic, Endocrine, Neurological, and Postoperative Diseases: A Comprehensive Narrative Review.
Journal: Medical sciences (Basel, Switzerland)
Published: March 20, 2026
Pathology of the digestive system organs in post-COVID syndrome according to autopsy data from 2021-2024
Journal: Arkhiv patologii
Published: January 27, 2026
Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome.
Journal: Journal of clinical medicine
Published: December 30, 2025
Clinical and morphological features and functional parameters in patients with gastroesophageal reflux disease and Barrett's esophagus
Journal: Terapevticheskii arkhiv
Published: June 02, 2025
Real-World Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal Syndrome.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: May 10, 2025
Tryptophan Metabolites in the Progression of Liver Diseases.
Journal: Biomolecules
Published: September 28, 2024
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study.
Journal: The lancet. Gastroenterology & hepatology
Published: September 16, 2024
Gut microbiota analysis in cirrhosis and non-cirrhotic portal hypertension suggests that portal hypertension can be main factor of cirrhosis-specific dysbiosis.
Journal: Scientific reports
Published: September 08, 2024
Effect of Saccharomyces boulardii on Liver Diseases: A Systematic Review.
Journal: Microorganisms
Published: August 01, 2024
Last Updated: 09/26/2026